Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses
journal contributionposted on 2022-06-16, 09:26 authored by N Lindson, A Theodoulou, J Livingstone-Banks, P Aveyard, TR Fanshawe, JM Ordóñez-Mena, AJ Sutton, SC Freeman, S Agrawal, J Hartmann-Boyce
Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To conduct component network meta-analyses (cNMAs) to investigate the comparative effectiveness, safety and tolerability of different smoking cessation pharmacotherapies and electronic cigarettes (EC), singly and combined, when helping people to stop smoking tobacco. To investigate:. how the different characteristics of smoking cessation pharmacotherapies and EC interventions (e.g. intervention subtype, dose, length of intervention, whether the intervention is used prequit as well as from quit date or from quit date only) influence efficacy, safety and tolerability; whether identifiable participant characteristics and behavioural support suggest different optimal intervention strategies.
National Institute for Health Research (NIHR), UK
Infrastructure funding for Cochrane Tobacco Addiction Group, Evidence Synthesis Programme Grant funding, NIHR senior investigator funding, Oxford Biomedical Research Centre (BRC) funding and Collaboration for Leadership in Applied Health Research and Care (CLAHRC) Oxford funding.
Author affiliationDepartment of Health Sciences, University of Leicester
- VoR (Version of Record)